Average Co-Inventor Count = 4.31
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (23 from 2,405 patents)
2. Merck Hdac Research, LLC (12 from 12 patents)
3. Sloan-kettering Institute for Cancer Research (7 from 512 patents)
4. Columbia University (4 from 2,487 patents)
5. Takeda Pharmaceutical Company Limited (4 from 1,177 patents)
6. Merck + Co., Inc. (3 from 4,770 patents)
7. University of Virginia (3 from 995 patents)
8. Other (2 from 832,680 patents)
9. Certa Therapeutics Pty Ltd. (2 from 3 patents)
10. Shire Human Genetic Therapies, Inc. (1 from 86 patents)
11. Merck Canada Inc. (1 from 40 patents)
12. Aton Pharma, Inc. (2 patents)
54 patents:
1. 12441724 - Inhibitors of plasma kallikrein and uses thereof
2. 11685912 - Affinity purification of glycosidase-cleaving enzymes
3. 11603349 - Anti-fibrotic compounds
4. 11352356 - Inhibitors of plasma kallikrein and uses thereof
5. 11168083 - Inhibitors of Plasma Kallikrein and uses thereof
6. 11014873 - Anti-fibrotic compounds
7. 10730874 - Inhibitors of plasma kallikrein and uses thereof
8. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
9. 9670196 - Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
10. 9096559 - 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
11. 8871796 - Diaryl ether derivatives as notch sparing gamma secretase inhibitors
12. 8796310 - Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors
13. 8686020 - Spirocyclic compounds
14. 8609897 - Trifluoromethylsulfonamide gamma secretase inhibitor
15. 8461189 - Pyridyl derivatives as histone deacetylase inhibitors